M1A.2190 Drug-induced chronic gout, unspecified shoulder, without tophus (tophi)

Name of the Condition

• Drug-Induced Chronic Gout, Unspecified Shoulder, Without Tophus (tophi)

Summary

Drug-induced chronic gout, unspecified shoulder, without tophus is a form of arthritis affecting the shoulder joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the presence of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the shoulder joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

• Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
• Prolonged exposure to urate-raising drugs
• Pre-existing hyperuricemia or gout history
• Renal impairment affecting drug clearance

Symptoms

• Recurrent episodes of intense shoulder pain, often with swelling and redness
• Persistent warmth and tenderness in the affected shoulder
• Stiffness and limited range of motion in the shoulder
• Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests to measure uric acid levels, and imaging studies to assess joint damage. A detailed medication history is critical to identify the drug-induced cause. Joint fluid analysis may be performed to rule out infection or other conditions.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include discontinuing or adjusting the causative medication, using anti-inflammatory drugs (e.g., NSAIDs or colchicine), and urate-lowering therapies (e.g., allopurinol or febuxostat). Lifestyle modifications, such as dietary changes, may also be recommended.

Prognosis and Follow-Up

With appropriate treatment, symptoms can be managed, and joint damage may be minimized. Regular follow-up is necessary to monitor uric acid levels and adjust therapy as needed. Long-term management is often required to prevent recurrence.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, persistent pain, and reduced mobility. In advanced stages, tophi may develop, though this code specifically excludes their presence.

Lifestyle & Prevention

• Avoid or limit use of medications known to raise uric acid levels when possible.
• Maintain a balanced diet low in purines (e.g., limit red meat, seafood, and alcohol).
• Stay hydrated to support uric acid excretion.
• Follow prescribed treatment plans consistently.

When to Seek Professional Help

Seek medical attention if you experience severe or worsening shoulder pain, swelling, or stiffness, especially if accompanied by fever or if symptoms do not improve with initial care.

Tips for Medical Coders

This code specifies drug-induced chronic gout affecting the unspecified shoulder without tophi. Ensure documentation confirms the absence of tophi and the shoulder as the affected site. Verify that the condition is linked to medication use and that chronic gout (not acute) is documented.